759 results on '"Sattler, Martin"'
Search Results
202. Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer
203. Targeting Angiogenesis via a c-Myc/Hypoxia-Inducible Factor-1α–Dependent Pathway in Multiple Myeloma
204. The MET axis as a therapeutic target
205. Grenzgänge zwischen Politik und Religion
206. Functional Oncogene Identification in Patient Leukemia Samples.
207. Novel Transforming Mutations of CBL in Human Acute Myeloid Leukemia
208. C-Myc- Dependent Stabilization of Hif-1alpha in MM: Therapeutic Implications
209. Mcl-1 Fragment Mcl-1(128–350) Induces Inhibition of Multiple Myeloma Cell Proliferation and Apoptosis Via Both Upregulation of C-Jun as Well as Modulation of Its Transcriptional Activity
210. Cell Cycle Regulation by Oncogenic Tyrosine Kinases in Myeloid Neoplasias: From Molecular Redox Mechanisms to Health Implications
211. EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC
212. Paxillin Is a Target for Somatic Mutations in Lung Cancer: Implications for Cell Growth and Invasion
213. BCR-ABL Induces Error-Prone Single Strand Annealing in Transformed Cells.
214. SB1518: A Potent and Orally Active JAK2 Inhibitor for the Treatment of Myeloproliferative Disorders.
215. The Tyrophostin Adaphostin (NSC680410) Inhibits Multiple Myeloma Bone Marrow Angiogenesis In Vitro and In Vivo.
216. Secondary Collapse of an Expandable Cage After Vertebral Corpectomy
217. Up-Regulation of c-Jun Inhibits Proliferation and Induces Apoptosis via Caspase-Triggered c-Abl Cleavage in Human Multiple Myeloma
218. c-Met and hepatocyte growth factor: Potential as novel targets in cancer therapy
219. Identification of novel therapeutic targets in acute leukemias with NRAS mutations using a pharmacologic approach.
220. The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma
221. The Jak2 V617F Oncogene Associated with Polycythemia Vera Requires a Functional FERM Domain for Transformation and for Expression of the Myc and Pim Proto-Oncogenes.
222. Upregulation of c-Jun Induces Cell Death Via Caspase-Triggered c-Abl Cleavage in Human Multiple Myeloma.
223. Activated Jak2 with the V617F Point Mutation Promotes G1/S Phase Transition
224. A sensitive high-throughput method to detect activating mutations of Jak2 in peripheral-blood samples
225. Novel targeted therapies to overcome imatinib mesylate resistance in chronic myeloid leukemia (CML)
226. The Jak2V617F Oncogene Associated with Polycythemia Vera Regulates G1/S-Phase Transition.
227. Targeting Src- Family Kinase Activation and Downstream Molecular Events To Overcome MM Cell Growth, Survival, and Drug- Resistance.
228. Up-Regulation of c-Jun contributes to the Induction of Apoptosis by Adaphostin in Human Multiple Myeloma Cells.
229. Local adjustment of the optical properties of metal island films by means of a laser
230. How to interfere with FLT3
231. Activation of the PI3K/mTOR pathway by BCR-ABL contributes to increased production of reactive oxygen species
232. The Tyrosine Kinase Inhibitor Adaphostin (NSC 680410), but Not Imatinib Mesylate, Inhibits Survival and Src Tyrosine Kinase Family- Triggered Signaling Pathways of MM Cells.
233. Pim Kinases Mediate Viability Signals Downstream of the Tyrosine Kinase Oncogenes BCR-ABL and FLT3-ITD.
234. Mitochondria and Caspase-Independent Cell-Death Triggered by GCS-100, a Novel Carbohydrate-Based Therapeutic in Multiple Myeloma (MM) Cells.
235. Caveolin-1 Is Required for VEGF- Triggered Multiple Myeloma Cell Migration and Is Targeted by Bortezomib (Velcade®).
236. Caveolin-1 Is Required for Vascular Endothelial Growth Factor-Triggered Multiple Myeloma Cell Migration and Is Targeted by Bortezomib
237. Targeting mutated tyrosine kinases in the therapy of myeloid leukaemias
238. Critical Role for Hematopoietic Cell Kinase (Hck)-mediated Phosphorylation of Gab1 and Gab2 Docking Proteins in Interleukin 6-induced Proliferation and Survival of Multiple Myeloma Cells
239. Targeting c-Kit mutations: basic science to novel therapies
240. Characterization of midostaurin as a dual inhibitor of FLT3 and SYK and potentiation of FLT3 inhibition against FLT3-ITD-driven leukemia harboring activated SYK kinase
241. Superoxide-dependent and -independent mitochondrial signaling during apoptosis in multiple myeloma cells
242. P-327 Role of HGF/c-Met signalling in lung cancer tumor-stromal interactions
243. O-306 Novel somatic mutations in the juxtamembrane domain of c-Met in small cell lung cancer: implications in cytoskeletal functions and cell motility
244. 2-Methoxyestradiol alters cell motility, migration, and adhesion
245. Molecular and cellular biology of small cell lung cancer
246. Essential Role of Caveolae in Interleukin-6- and Insulin-like Growth Factor I-triggered Akt-1-mediated Survival of Multiple Myeloma Cells
247. Critical role for Gab2 in transformation by BCR/ABL
248. Vascular Endothelial Growth Factor-induced Migration of Multiple Myeloma Cells Is Associated with β1 Integrin- and Phosphatidylinositol 3-Kinase-dependent PKCα Activation
249. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells
250. Cell Motility, Adhesion, Homing, and Migration Assays in the Studies of Tyrosine Kinases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.